Lilly Shells Out $6.3 Billion For Boston Sleep-Drug Player Centessa
Eli Lilly will buy Boston‑based Centessa for about $6.3B, adding an orexin agonist program led by cleminorexton. The deal pays $38 per ADS up front and could reach $47 with milestones.
Speed Freaks Rejoice: Clear Lanes Headed to Indianapolis Airport This Summer
Clear will add paid biometric lanes at Indianapolis International Airport this summer, promising faster ID checks for members and a modest boost in local jobs. The airport authority approved the deal in late March.
Noblesville Teen’s Pro-Life Flyers Spark Supreme Court Showdown
A Noblesville High School freshman has asked the U.S. Supreme Court to decide whether schools may ban student flyers with political slogans. The petition challenges a Seventh Circuit ruling that sided with the district.
Indy Council Sounds Alarm on LEAP Water Deal, Puts Eagle Creek on the Line
Councilors and residents say a state-backed water program tied to the LEAP district could put Eagle Creek Park at risk, citing treated wastewater plans and transparency gaps. They want stronger guarantees before Indianapolis stays involved.











-2.webp?max-h=350&w=550&fit=crop)
